To cite this article: Jones S, Ignjatovic V, Monagle P, Newall F. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis: comment. J Thromb Haemost 2015; 13: 160-1.See also Vidal E, Sharathkumar A, Glover J, Faustino EVS. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis. J Thromb Haemost 2014; 12: 1096-109 and Vidal E, Sharathkumar A, Glover J, Faustino EVS.Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis: reply. This issue, pp 161-2.We write in response to the article titled 'Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis' [1]. A key finding of this study was that nearly 20% of children with central venous catheters (CVCs) develop a thrombosis and that to date, pediatric thromboprophylaxis studies have not achieved a significant reduction in the CVCrelated deep vein thrombosis (DVT) event rate, despite similar studies in adult patients achieving such a reduction. Vidal et al. suggest the development of a randomized controlled trial of CVC thromboprophylaxis as the logical next step towards providing optimal clinical management of children requiring a CVC.We concur with the authors that the appreciable risk of CVC-related DVT in children is leading many institutions to develop their own thromboprophylaxis clinical guidelines based on questionable evidence. Despite the growing trend of providing CVC-related DVT thromboprophylaxis, routine screening for CVC-related DVT is not advocated and the true rate of complications from asymptomatic CVC-related DVT is unknown. The PARKAA study, a large cohort study, prospectively enrolled children with acute lymphoblastic leukemia with a CVC in situ and performed scheduled imaging for the duration of the study [2]. The prevalence of venous thromboembolism (VTE) was 36.7%; however, only three patients (5%) had clinically symptomatic VTE.We do not agree with Vidal et al. that the development of a randomized controlled trial of CVC-related DVT thromboprophylaxis is the logical next step towards improved outcomes for these patients. Whilst symptomatic and asymptomatic CVC-related DVT can have serious sequalae, including post-thrombotic syndrome (PTS), stroke and pulmonary hypertension (PH) [3][4][5], the true rates of short or long-term adverse events following CVC-related DVT in children remain unknown [6,7]. In addition, anticoagulation therapy confers a significant risk of bleeding (up to 56%) and exposes children to traumatic venous blood monitoring [8,9].In addition to the paucity of data regarding the natural history of CVC-related DVT, questions have been raised as to the role of ultrasound screening in assisting in early detection [10,11]. Early detection of CVC-related VTE facilitates timely anticoagulation therapy and may prevent both progression and embolization of the VTE. Yet to our knowledge, no study h...